Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells
Moreover, FSP1, a CoQ 10 oxidoreductase recently identified at the plasma membrane, was previously known as apoptosis-inducing factor mitochondria-associated 2 (AIFM2) 37
Medical science has made such tremendous progress that there is hardly a healthy human left. Aldous Huxley GLP-1 Agonists at a Glance First-Generation (Short-Acting) Exenatide Byetta Lixisenatide Adlyxin / Lyxumia Second-Generation (Long-Acting) Exenatide ER Bydureon (weekly, now discontinued in some markets) Liraglutide Victoza (diabetes), Saxenda (obesity) Dulaglutide Trulicity Semaglutide Ozempic (diabetes), Wegovy (obesity), Rybelsus (oral) Dual Agonist (GIP + GLP-1) Tirzepatide Mounjaro (diabetes), Zepbound (obesity) Triple or Combination Agonists (In Development) Retatrutide Triple agonist (GLP-1 + GIP + glucagon) CagriSema Combination of cagrilintide + semaglutide (GLP-1 + amylin analog) Orforglipron Oral, non-peptide GLP-1 receptor agonist (Eli Lilly) Danuglipron Oral small-molecule GLP-1 agonist (Pfizer) Efinopegdutide GLP-1/glucagon dual agonist (Merck/Biocon) AMG133 GLP-1 + GIP receptor modulator (Amgen)
Research subjects should be fully informed about: The nature and purpose of the research Possible risks and adverse effects Tracking procedures Right to withdraw from research Confidentiality protections Contact data for questions or concerns Regulatory Considerations Researchers should be aware of control frameworks governing peptide research in their jurisdiction
J Am Acad Dermatol 77(4):773774
A Western-style diet induces benign and malignant neoplasms in the colon of normal C57BL/6 mice
